Global Challenges In 2003: Japanese Pricing, EU Reclassifications
This article was originally published in The Gray Sheet
Executive Summary
European regulatory authorities are on the verge of upclassifying several surgically invasive device categories, despite fervent Eucomed-led opposition mounted during 2003
You may also be interested in...
United They Stand? Differing Device Platforms Share FDA Oversight Plank
Device advocacy groups credit a maturing industry presence on Capitol Hill, reflected by CEO-level participation, with achieving relevant Medicare reforms and a focus on FDA accountability
Japanese Price Caps: Industry Aims For New Product Payment Group Inclusion
Changes to Japan's C1 and C2 new product payment categories will create incentives for foreign firms to launch products in the country, AdvaMed maintains
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.